註冊並分享邀請連結,可獲得影片播放與邀請獎勵。

Bloomberg
@business
The first word in business news | Watch Live: | Newsletters: | Podcasts:
加入 April 2009
107 正在關注    10.5M 粉絲
CSL agreed to pay as much as $1.6 billion to jointly develop and sell an experimental treatment for rare kidney and liver diseases, expanding the Australian biotech company’s push into kidney medicine
顯示更多